135 related articles for article (PubMed ID: 21142090)
1. Injectable thermally responsive mucoadhesive gel for sustained protein delivery.
Mayol L; Biondi M; Quaglia F; Fusco S; Borzacchiello A; Ambrosio L; La Rotonda MI
Biomacromolecules; 2011 Jan; 12(1):28-33. PubMed ID: 21142090
[TBL] [Abstract][Full Text] [Related]
2. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties.
Mayol L; Quaglia F; Borzacchiello A; Ambrosio L; La Rotonda MI
Eur J Pharm Biopharm; 2008 Sep; 70(1):199-206. PubMed ID: 18644705
[TBL] [Abstract][Full Text] [Related]
3. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide.
Yuan Y; Cui Y; Zhang L; Zhu HP; Guo YS; Zhong B; Hu X; Zhang L; Wang XH; Chen L
Int J Pharm; 2012 Jul; 430(1-2):114-9. PubMed ID: 22503953
[TBL] [Abstract][Full Text] [Related]
4. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity.
Jones DS; Bruschi ML; de Freitas O; Gremião MP; Lara EH; Andrews GP
Int J Pharm; 2009 May; 372(1-2):49-58. PubMed ID: 19429268
[TBL] [Abstract][Full Text] [Related]
5. Sustained release of lidocaine from Poloxamer 407 gels.
Ricci EJ; Lunardi LO; Nanclares DM; Marchetti JM
Int J Pharm; 2005 Jan; 288(2):235-44. PubMed ID: 15620863
[TBL] [Abstract][Full Text] [Related]
6. Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network.
Chung TW; Lin SY; Liu DZ; Tyan YC; Yang JS
Int J Pharm; 2009 Dec; 382(1-2):39-44. PubMed ID: 19666095
[TBL] [Abstract][Full Text] [Related]
7. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels.
Ur-Rehman T; Tavelin S; Gröbner G
Int J Pharm; 2011 May; 409(1-2):19-29. PubMed ID: 21335076
[TBL] [Abstract][Full Text] [Related]
8. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid on the urokinase sustained release with a hydrogel system composed of poloxamer 407: HA/P407 hydrogel system for drug delivery.
Hsieh HY; Lin WY; Lee AL; Li YC; Chen YJ; Chen KC; Young TH
PLoS One; 2020; 15(3):e0227784. PubMed ID: 32160196
[TBL] [Abstract][Full Text] [Related]
10. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
[TBL] [Abstract][Full Text] [Related]
11. [Diffusion behaviors of drugs in thermosensitive in situ gels].
Wei G; Lu WY; Zheng JM
Yao Xue Xue Bao; 2004 Mar; 39(3):232-5. PubMed ID: 15171663
[TBL] [Abstract][Full Text] [Related]
12. Assessment of release kinetics, stability and polymer interaction of poloxamer 407-based thermosensitive gel of interleukin-1 receptor antagonist.
Akash MS; Rehman K; Sun H; Chen S
Pharm Dev Technol; 2014 May; 19(3):278-84. PubMed ID: 23506246
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the rheological and mucoadhesive properties of thermosensitive poloxamer-based hydrogels intended for the rectal administration of quinine.
Koffi AA; Agnely F; Ponchel G; Grossiord JL
Eur J Pharm Sci; 2006 Mar; 27(4):328-35. PubMed ID: 16356700
[TBL] [Abstract][Full Text] [Related]
14. Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties.
Liu Y; Zhu YY; Wei G; Lu WY
Eur J Pharm Sci; 2009 Jun; 37(3-4):306-12. PubMed ID: 19491020
[TBL] [Abstract][Full Text] [Related]
15. Improved delivery of angiogenesis inhibitors from PLGA:poloxamer blend micro- and nanoparticles.
d'Angelo I; Parajó Y; Horváth A; Kéri G; La Rotonda MI; Alonso MJ
J Microencapsul; 2010; 27(1):57-66. PubMed ID: 19545221
[TBL] [Abstract][Full Text] [Related]
16. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery.
Gratieri T; Gelfuso GM; Rocha EM; Sarmento VH; de Freitas O; Lopez RF
Eur J Pharm Biopharm; 2010 Jun; 75(2):186-93. PubMed ID: 20188828
[TBL] [Abstract][Full Text] [Related]
17. Tuneable semi-synthetic network alginate for absorptive encapsulation and controlled release of protein therapeutics.
Chan AW; Neufeld RJ
Biomaterials; 2010 Dec; 31(34):9040-7. PubMed ID: 20739057
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of morphine from a poloxamer 407 gel.
Jansen MM; Verzijl JM; Burger DM; Hekster YA
Int J Pharm; 2013 Aug; 452(1-2):266-9. PubMed ID: 23707252
[TBL] [Abstract][Full Text] [Related]
19. Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base.
Baloglu E; Karavana SY; Senyigit ZA; Guneri T
Pharm Dev Technol; 2011; 16(6):627-36. PubMed ID: 20715905
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of thermosensitive poloxamer 407 gel systems for the sustained release of estradiol in a fish model.
Cespi M; Bonacucina G; Pucciarelli S; Cocci P; Perinelli DR; Casettari L; Illum L; Palmieri GF; Palermo FA; Mosconi G
Eur J Pharm Biopharm; 2014 Nov; 88(3):954-61. PubMed ID: 25194925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
